BloggingStocks has a new home! Daily Finance.

Click here to visit the new home of BloggingStocks!

Hot on DailyFinance:

See More Stories

AOL
MAIL

Options Update: Clinical biotechnology stocks volatility near average

Posted Aug 25th 2009 8:00AM by Paul Foster
Filed under: Options

Theravance (NASDAQ: THRX) biotechnology company closed at $15.22. THRX September volatility is at 65, October is at 72, December is at 78 verses its 26-week average of 78 according to Track Data, suggesting decreasing near term price movement.

Seattle Genetics (NASDAQ: SGEN) a clinical stage biotechnology company, closed at $12.09. SGEN October and March 2010 option implied volatility of 60 is near its 26-week average according to Track Data, suggesting non-directional price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Tags: biotechnology, clinical stage biotechnology company, ClinicalStageBiotechnologyCompany, option implied volatility, OptionImpliedVolatility

Indexes	Change	Price
DJIA	+64.22	12,865.45
NASDAQ	+22.48	2,926.36
S&P 500	+8.58	1,351.22

Last updated: February 13, 2012: 01:46 PM

Hot Stocks

General Electric

19.035+0.16(+0.85)

Alcoa

10.35+0.06(+0.58)

Apple Inc

499.58+6.16(+1.25)

Google Inc 'A'

612.46+6.55(+1.08)

Bank of America

8.295+0.225(+2.79)

Wal-Mart Stores

61.91+0.01(+0.02)

Exxon Mobil Corp

84.41+0.61(+0.73)

Ford

12.57+0.13(+1.04)

Citigroup

33.39+0.465(+1.41)

IBM

192.74+0.32(+0.17)

Yahoo

16.155+0.015(+0.09)

Starbucks

49.23+0.41(+0.84)

Microsoft

30.58+0.085(+0.28)

Home Depot

46.07+0.74(+1.63)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329158791679 ms.